ERSP Finds Troy Can Support Certain Claims For Vepygen But Recommends Marketer Modify, Discontinue Certain Claims
New York, NY – Dec. 7, 2010 – The Electronic Retailing Self-Regulation Program (ERSP) has determined that Troy LLC provided adequate support for general performance claims for the Vepygen Anti-Stretch Mark Complex, but recommended the marketer modify or discontinue certain claims, including “Doctor Recommended” claims.
ERSP, the electronic direct-response industry’s self-regulatory forum, is administered by the Council of Better Business Bureaus (CBBB) with policy oversight by the National Advertising Review Council (NARC).
The marketer’s advertising came to the attention of ERSP through ERSP’s routine monitoring efforts.
ERSP examined claims in broadcast, radio, and online advertising that included:
- “Reduce the appearance of stretch marks”
- “Permanent, Dramatic Visible Results Within Weeks!”
- “100% Guaranteed Results”
- “safe and effective for all skin types!”
- “Clinically Proven 4X Stronger!”; “…clinically proven to be four times stronger and effective at preventing and reducing the appearance of stretch marks”
- “Contains Regestril – A Clinically Proven Patented Complex From France That Can Reduce The Appearance Of Stretch marks!”
- “Doctor Recommended”
Following its review of the evidence, which included both laboratory and human testing, ERSP determined that the marketer provided a reasonable basis for core general performance claims related to a reduction in the appearance of stretch marks.
However, ERSP determined that several other core performance claims – including the length of time required to achieve results, the permanency of results, and the efficacy and safety of the product on various skin types – were not supported by the evidence in the record.
ERSP further determined that the marketer’s “guarantee” claims – which relate to a money-back guarantee for customers who are not satisfied – were not properly supported in the context of the advertising at issue.
ERSP determined that the marketer’s clinical evidence on the product’s active ingredient provided a sufficient basis for the core claim that the product “Contains Regestril – A Clinically Proven Patented Complex From France That Can Reduce The Appearance Of Stretch marks!” ERSP determined, however, that the marketer’s “4X stronger” claim was not supported and recommended the claim be discontinued.
ERSP recommended that the marketer discontinue a “Doctor Recommended” claim. Finally, ERSP found that the marketer’s evidence did not support claims included in consumer testimonials and determined that disclosure language used in conjunction with testimonials was insufficient to communicate to consumers that the results describe are atypical.
The company, in its marketer’s statement, said “we have decided to accept ERSP’s recommendations in its entirety and will make the minor recommended modifications to our advertising.”
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
Latest Decisions
National Advertising Division Refers “Made in USA” Claims by Larose Industries d/b/a Roseart and Cra-Z-Art to the Federal Trade Commission
New York, NY – January 10, 2025 – The National Advertising Division referred advertising claims by Larose Industries, operating under the names Roseart and Cra-Z-Art, that its products are “Made in USA” to the Federal Trade Commission (FTC) after Larose Industries failed to respond to the inquiry.
National Advertising Division Recommends T-Mobile Discontinue or Modify 20% Savings vs. ‘The Other Big Guys’ Claim; T-Mobile to Appeal
New York, NY – January 9, 2025 – The National Advertising Division recommended that T-Mobile discontinue or modify its advertising to avoid conveying the comparative claim that consumers can “save 20% every month vs. the other big guys” if they subscribe to T-Mobile in markets where Spectrum Mobile also...
In National Advertising Division Fast-Track SWIFT Challenge Behr Voluntarily Discontinues “No Comparable Product” Claim
New York, NY – January 8, 2025 – In a National Advertising Division Fast-Track SWIFT challenge brought by Benjamin Moore, Behr voluntarily discontinued its “No Comparable Product” claim.
National Advertising Division Finds Charter’s “Unlimited” Claims Supported; Recommends Clear & Conspicuous Speed Limitation Disclosures
New York, NY – January 7, 2025 – The National Advertising Division found that Charter substantiated certain express and implied claims about its Spectrum Mobile “Unlimited” and “Unlimited Plus” wireless data plans but recommended that Charter modify its website advertising to disclose high speed data...